Maejima, Yuko

Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass

Maejima, Y., Iwasaki, Y., Yamahara, Y., Kodaira, M., Sedbazar, U., & Yada, T. (2011) · Aging

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 220

Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: A route for ameliorating hyperphagia and obesity

Iwasaki, Y., Maejima, Y., Suyama, S., Yoshida, M., Arai, T., Katsurada, K., Kumari, P., Nakabayashi, H., Kakei, M., & Yada, T. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 148

Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas

Maejima, Y., Rita, R. S., Santoso, P., Aoyama, M., Hiraoka, Y., Nishimori, K., Gantulga, D., Shimomura, K., & Yada, T. (2015) · Neuroendocrinology

Regulation of Appetite and ObesityNeuroendocrine regulation and behavior

Cited by 81

The deletion of glucagon-like peptide-1 receptors expressing neurons in the dorsomedial hypothalamic nucleus disrupts the diurnal feeding pattern and induces hyperphagia and obesity

Maejima, Y., Yokota, S., Shimizu, M., Horita, S., Kobayashi, D., Hazama, A., & Shimomura, K. (2021) · Nutrition & Metabolism

Regulation of Appetite and ObesityCircadian rhythm and melatonin

Cited by 21

Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto–Kakizaki rats

Maekawa, F., Fujiwara, K., Toriya, M., Maejima, Y., Nishio, T., Toyoda, Y., Nohara, K., Yashiro, T., & Yada, T. (2013) · Frontiers in Synaptic Neuroscience

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 19